USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 2, 2022 | Jun 2022 | $-0.08 | - | $-0.07 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 2, 2022 | Jun 2022 | $6.25M | - | $3.86M |
Bionano Genomics, Inc's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 4 | $-0.08 | $-0.10 | $-0.05 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $-0.33 | $-0.39 | $-0.28 |
| Dec 2023 | 4 | $-0.32 | $-0.41 | $-0.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $-0.07 | $-0.06 | $-0.06 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-0.30 | $-0.26 | $-0.28 |
| Dec 2023 | 0 / 0 | $-0.29 | $-0.25 | $-0.28 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 4 | $6.25M | $6.10M | $6.46M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $25.95M | $25.20M | $26.92M |
| Dec 2023 | 4 | $46.77M | $39.80M | $61.07M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 11, 2022 | Mar 2022 | $-0.07 | - | - |
| Mar 1, 2022 | Dec 2021 | $-0.06 | $-0.08 | -33.33% |
| Nov 4, 2021 | Sep 2021 | $-0.06 | $-0.07 | -21.74% |
| Aug 4, 2021 | Jun 2021 | $-0.05 | $-0.07 | -55.56% |
| May 13, 2021 | Mar 2021 | $-0.05 | $-0.04 | 11.11% |
| Mar 23, 2021 | Dec 2020 | $-0.05 | $-0.05 | 4.76% |
| Nov 13, 2020 | Sep 2020 | $-0.06 | $-0.08 | -41.09% |
| Aug 13, 2020 | Jun 2020 | $-0.09 | $-0.09 | -3.81% |
| Jun 18, 2020 | Mar 2020 | $-0.22 | $-0.30 | -39.53% |
| Mar 5, 2020 | Dec 2019 | $-0.18 | $-0.30 | -66.67% |
| Nov 7, 2019 | Sep 2019 | $-0.60 | $-0.59 | 1.67% |
| Aug 8, 2019 | Jun 2019 | $-0.62 | $-0.71 | -15.45% |
| May 9, 2019 | Mar 2019 | $-0.57 | $-0.77 | -36.28% |
| Mar 14, 2019 | Dec 2018 | $-0.46 | $-0.62 | -34.78% |
| Nov 7, 2018 | Sep 2018 | $-0.49 | $-0.49 | -1.03% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 1, 2022 | Dec 2021 | $-0.25 | $-0.26 | - |
| Mar 23, 2021 | Dec 2020 | $-0.40 | $-0.52 | - |
| Mar 5, 2020 | Dec 2019 | $-2.03 | $-2.37 | - |
| Mar 14, 2019 | Dec 2018 | $-2.28 | $-1.11 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 11, 2022 | Mar 2022 | $5.68M | - | - |
| Mar 1, 2022 | Dec 2021 | $5.57M | $6.30M | 1.13% |
| Nov 4, 2021 | Sep 2021 | $4.23M | $4.66M | 1.10% |
| Aug 4, 2021 | Jun 2021 | $3.86M | $3.86M | 1.00% |
| May 13, 2021 | Mar 2021 | $2.90M | $3.17M | 1.09% |
| Mar 23, 2021 | Dec 2020 | $3.50M | $3.99M | 1.14% |
| Nov 13, 2020 | Sep 2020 | $2.07M | $2.20M | 1.06% |
| Aug 13, 2020 | Jun 2020 | $860.00K | $1.18M | 1.37% |
| Jun 18, 2020 | Mar 2020 | $1.70M | $1.14M | 0.67% |
| Mar 5, 2020 | Dec 2019 | $2.79M | $2.79M | 1.00% |
| Nov 7, 2019 | Sep 2019 | $3.31M | $3.31M | 1.00% |
| Aug 8, 2019 | Jun 2019 | $2.38M | $2.17M | 0.91% |
| May 9, 2019 | Mar 2019 | $1.85M | $1.85M | 1.00% |
| Mar 14, 2019 | Dec 2018 | $3.34M | $4.01M | 1.20% |
| Nov 7, 2018 | Sep 2018 | $2.45M | $2.83M | 1.15% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 1, 2022 | Dec 2021 | $17.26M | $17.98M | 4.18% |
| Mar 23, 2021 | Dec 2020 | $8.01M | $8.50M | 6.15% |
| Mar 5, 2020 | Dec 2019 | $10.13M | $10.13M | 0.01% |
| Mar 14, 2019 | Dec 2018 | $11.46M | $12.00M | 4.72% |
BNGO's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Bionano Genomics, Inc's next quarterly earnings is $-0.08, with a low EPS estimation of $-0.10, and a high estimation of $-0.05.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.07, the last 2 month trend is $-0.06, and the 3 month trend is $-0.06.
Based on analysts, the average revenue estimation is $6.25M, with a low revenue estimation of $6.10M, and a high estimation of $6.46M.
Bionano Genomics, Inc's previous earnings date was May 11, 2022 for its fiscal quarter ended Mar 31, 2022.
Bionano Genomics, Inc's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.
BNGO's earnings per share (EPS) was $-0.26, missing the consensus analysts forecast of $-0.25 by 4.00% , and higher than the previous year's EPS (Dec 2020) by -50.00%.
Revenues were $17.98M, better than the forecast of $17.26M by 4.18%, and up by 111.47% from previous year's revenue.
The company reported a net income of $-72.44M.
Bionano Genomics, Inc reported a free cash flow of $-72.75M for its fiscal year, compared to $-38.31M a year ago.
The company ended the fiscal year with $12.34M in total debt, a decrease of -66.10% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
